Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02200718
Recruitment Status : Not yet recruiting
First Posted : July 25, 2014
Last Update Posted : February 23, 2016
Sponsor:
Collaborator:
Oregon Health and Science University
Information provided by (Responsible Party):
Immune Response BioPharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : November 2019
Estimated Study Completion Date : November 2019